Read by Professor David Nutt

On Sale: Jan 2, 2024
Publisher: Hachette Audio
ISBN-13: 9781668640883

$24.99

Format

Format:

Audiobook Download (Unabridged) $24.99
ebook $11.99 $15.99 CAD
Trade Paperback $19.99 $25.99 CAD

Buy from Other Retailers:

The definitive guide to the science of psychedelics and how they can impact our health by world-renowned, leading authority Professor David Nutt.

We are on the cusp of a major revolution in psychiatric medicine and neuroscience. After fifty years of prohibition, criminalization and fear, science is finally showing us that psychedelics are not dangerous or harmful. Instead, when used according to tested, safe and ethical guidelines, they are our most powerful newest treatment of mental health conditions, from depression, PTSD, and OCD to disordered eating and even addiction and chronic pain.

Professor David Nutt, one of the world’s leading Neuropsychopharmacologists, has spent 15 years researching this field and it is his most significant body of work to date. In 2018, he co-founded the first academic psychedelic research center – underpinned by his mission to provide evidence-based information for people everywhere. It revived interest in the understanding and use of this drug in its many forms, including MDMA, ayahuasca, magic mushrooms, LSD and ketamine. The results of this have been nothing short of ground-breaking for the future categorization of drugs, but also for what we now know about brain mechanisms and our consciousness.

At a time where there is an enormous amount of noise around the benefits of psychedelics, this book contains the knowledge you need to know about a drug that is about to go mainstream, free from the hot air, direct from the expert.

Are you ready to change your mind?

Genre:

By clicking ‘Sign Up,’ I acknowledge that I have read and agree to Hachette Book Group’s Privacy Policy and Terms of Use

Professor David Nutt

About the Author

David Nutt is a leading global authority on alcohol abuse. He is a professor of neuropsychopharmacology and director of the Neuropsychopharmacology Unit at Imperial College, London. He spent two years as Chief of the Section of Clinical Science in the National Institute of Alcohol Abuse and Alcoholism at the NIH. David is also currently the chair of DrugScience, president of the European Brain Council, and the UK director of the European Certificate and Masters in Affective Disorders Courses.

David broadcasts widely to the general public both on radio and television, including BBC science and public affairs programs on therapeutic as well as illicit drugs, their harms, and their classification.

Learn more about this author

Contributors

Formats and Prices

Price